SafePharm Labs Logo
Login
Password
Sign Up Here Lost Password?
 
Testing Services
 
Endpoint: Skin Corrosivity
Endpoints: Skin and Eye Irritation
Skin Irritancy Tests using Human Skin Models
Ocular Irritancy Ex Vivo
Endpoint: Mucosal Irritancy
Endpoint: Phototoxicity Testing
Endpoint: In Vitro Dermal Penetration
Endpoint: Skin (Contact) Sensitisation
QSAR
Future Prospects

dots
line  
rcc logo and website link
harlan logo and website
harlan europe logo and website
harlan teklad

To view the documents within this site you will need to have or download

For a list of commonly used abbreviations please download.

word

Alternative Toxicology - Endpoint: Phototoxicity Testing

In Vitro 3T3 NRU Phototoxicity Test

Phototoxicity can be defined as a toxic response to a substance after the first exposure to certain chemicals and subsequent exposure to light, or that is induced by skin irradiation after systemic administration of a chemical. The in vitro 3T3 Neutral Red Uptake (NRU) phototoxicity test is used to identify the phototoxic potential of a test substance after exposure to light. The test is based on a comparison of the cytotoxicity of a chemical in the presence and in the absence of a non-cytotoxic dose of UVA. Cytotoxicity in this test is expressed as a concentration-dependant reduction of the uptake of the vital dye, Neutral Red in Balb/c 3T3 cells when measured 24 hours after treatment with the test substance and irradiation.

The 3T3 NRU Phototoxicity test is used for the assessment of phototoxic potential as indicated in the OECD Guideline for the Testing of Chemicals, No. 432 “In Vitro 3T3 NRU phototoxicity test” and the Method B40 of Annex V to Directive 67/548/EEC (Council Directive 2000/33/EEC).

 


 

SkinEthic Human Reconstituted Epidermal (HRE) Model
 
The HRE Model is an appropriate model for the determination of phototoxic potency of formulations containing known phototoxic ingredients (e.g. intended for photo-dynamic therapy), or for screening of products prior to assessment of photoallergenicity in vivo. With this model it is possible to apply the product directly to the surface of the epidermis and then to irradiate the tissue with ultra-violet or visible light. The degree of phototoxic response can then be assessed by multi endpoint analysis (see above).

 

 

 

 

 

 

 

 

 

 
This site is best viewed with Internet Explorer 6.0+ or Netscape Navigator 7+, at a minimum screen resolution of 800 x 600, and a minimum modem connection speed of 56Kbps.
Copyright © SafePharm Laboratories 2006-2007. All rights reserved. //
terms & conditions // website design trondez.com